• Research Topics

  PrimeC – Positive Results in Phase IIa Clinical Study in ALS

  Posted by Richard on March 2, 2021 at 11:12 am

  Hi All,

  NeuroSense Therapeutics recently reported positive results in a PrimeC clinical study in ALS, announcing the successful completion of its first Phase IIa study. The successful completion of this trial paves the way for PrimeC to become a leading candidate in the fight against ALS.

  https://www.prnewswire.com/il/news-releases/neurosense-therapeutics-reports-positive-results-in-phase-iia-clinical-study-in-als-and-patent-allowance-in-the-usa-for-primec-301238515.html

   

  Is this more hype or hope?

   

  Richard

   

  Richard replied 3 years, 2 months ago 0 Member · 0 Replies

  • ALS
  • research
• 0 Replies

Log In to Reply